Department of Chemical, Pharmaceutical and Agricultural Sciences (DoCPAS), University of Ferrara, 44121 Ferrara, Italy.
Biotechnology Inter University Consortium (C.I.B.), Ferrara Section, University of Ferrara, 44121 Ferrara, Italy.
Molecules. 2024 Jul 20;29(14):3407. doi: 10.3390/molecules29143407.
The present study investigates the possible use of manganese (Mn)-based liposomal formulations for diagnostic applications in imaging techniques such as magnetic resonance imaging (MRI), with the aim of overcoming the toxicity limitations associated with the use of free Mn. Specifically, anionic liposomes carrying two model Mn(II)-based compounds, MnCl (MC) and Mn(HMTA) (MH), were prepared and characterised in terms of morphology, size, loading capacity, and in vitro activity. Homogeneous dispersions characterised mainly by unilamellar vesicles were obtained; furthermore, no differences in size and morphology were detected between unloaded and Mn-loaded vesicles. The encapsulation efficiency of MC and MH was evaluated on extruded liposomes by means of ICP-OES analysis. The obtained results showed that both MC and MH are almost completely retained by the lipid portion of liposomes (LPs), with encapsulation efficiencies of 99.7% for MC and 98.8% for MH. The magnetic imaging properties of the produced liposomal formulations were investigated for application in a potential preclinical scenario by collecting magnetic resonance images of a phantom designed to compare the paramagnetic contrast properties of free MC and MH compounds and the corresponding manganese-containing liposome dispersions. It was found that both LP-MC and LP-MH at low concentrations (0.5 mM) show better contrast (contrast-to-noise ratios of 194 and 209, respectively) than solutions containing free Mn at the same concentrations (117 and 134, respectively) and are safe to use on human cells at the selected dose. Taken together, the results of this comparative analysis suggest that these liposome-containing Mn compounds might be suitable for diagnostic purposes.
本研究探讨了基于锰(Mn)的脂质体制剂在磁共振成像(MRI)等成像技术中的诊断应用的可能性,旨在克服与使用游离 Mn 相关的毒性限制。具体而言,制备了携带两种模型 Mn(II)基化合物 MnCl(MC)和 Mn(HMTA)(MH)的阴离子脂质体,并对其形态、粒径、载药量和体外活性进行了表征。获得了主要由单层囊泡组成的均匀分散体;此外,未负载和负载 Mn 的囊泡之间在大小和形态上没有差异。通过 ICP-OES 分析评估了 MC 和 MH 在挤出脂质体中的包封效率。所得结果表明,MC 和 MH 几乎完全被脂质体(LPs)的脂质部分保留,MC 的包封效率为 99.7%,MH 的包封效率为 98.8%。通过收集设计用于比较游离 MC 和 MH 化合物和相应的含锰脂质体分散体的顺磁对比特性的幻影的磁共振图像,研究了所制备的脂质体制剂的磁成像特性,以应用于潜在的临床前情况。结果发现,在低浓度(0.5 mM)下,LP-MC 和 LP-MH 显示出比相同浓度下(分别为 117 和 134)的游离 Mn 溶液更好的对比度(对比噪声比分别为 194 和 209),并且在选定剂量下对人细胞安全使用。综上所述,这项比较分析的结果表明,这些含锰脂质体化合物可能适合用于诊断目的。